Article

Identification of Potential Biomarkers to Predict Organ Morbidity in COVID-19: A Repository Based Proteomics Perspective

2023-02-27

Abstract excerpt

SARS-CoV-2 causes substantial extrapulmonary manifestations in addition to pulmonary disease. Some of the major organs affected are cardiovascular, hematological and thrombotic, renal, neurological, and digestive systems. These types of muti-organ dysfunctions make it difficult and challenging for clinicians to manage and treat COVID-19 patients. The article focuses to identify potential protein biomarkers that ca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c0893ffa-0866-53ef-82f9-06265d5e22b2
DOI: 10.2139/ssrn.4367214

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Identification of Potential Biomarkers to Predict Organ Morbidity in COVID-19: A Repository Based Proteomics PerspectiveDOI 10.2139/ssrn.4367214Read

Large-scale Multi-omic Analysis of COVID-19 SeveritySemantic proximity Read

Prediction of severe adverse events, modes of action and drug treatments for COVID-19's complications.Semantic proximity Read

Organ and cell-specific biomarkers of Long-COVID identified with targeted proteomics and machine learningSemantic proximity Read

COVID-19 Biomarkers in research: Extension of the OncoMX cancer biomarker data model to capture biomarker data from other diseasesSemantic proximity Read

Multi-omics approach to COVID-19: a domain-based literature reviewSemantic proximity Read

A novel multi-omics-based identification of symptoms, comorbid conditions, and possible long-term complications in COVID-19Semantic proximity Read

Inflammation Patterns in Omicron Variant-Linked COVID-19: Assessing Biomarkers for Predicting Disease SeveritySemantic proximity Read

Plasma Proteomics Identify Biomarkers and Pathogenesis of COVID-19Semantic proximity Read

An In-Depth Insight into Clinical, Cellular and Molecular Factors in COVID-19-Associated Cardiovascular Ailments for Identifying Novel Disease Biomarkers, Drug Targets and Clinical Management StrategiesSemantic proximity Read

MOATAI-VIR - an AI algorithm that predicts severe adverse events and molecular features for COVID-19’s complicationsSemantic proximity Read

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read

Identification of common molecular signatures of SARS-CoV-2 infection and its influence on acute kidney injury and chronic kidney diseaseSemantic proximity Read